IRIS Accounts Production v24.1.9.2 11251710 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh112517102023-03-31112517102024-03-31112517102023-04-012024-03-31112517102022-03-31112517102022-04-012023-03-31112517102023-03-3111251710ns15:EnglandWales2023-04-012024-03-3111251710ns14:PoundSterling2023-04-012024-03-3111251710ns10:Director12023-04-012024-03-3111251710ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3111251710ns10:SmallEntities2023-04-012024-03-3111251710ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3111251710ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3111251710ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3111251710ns10:FullAccounts2023-04-012024-03-3111251710ns10:OrdinaryShareClass12023-04-012024-03-3111251710ns10:OrdinaryShareClass22023-04-012024-03-3111251710ns10:OrdinaryShareClass32023-04-012024-03-3111251710ns10:OrdinaryShareClass42023-04-012024-03-3111251710ns10:Director22023-04-012024-03-3111251710ns10:Director32023-04-012024-03-3111251710ns10:CompanySecretary12023-04-012024-03-3111251710ns10:RegisteredOffice2023-04-012024-03-3111251710ns5:CurrentFinancialInstruments2024-03-3111251710ns5:CurrentFinancialInstruments2023-03-3111251710ns5:ShareCapital2024-03-3111251710ns5:ShareCapital2023-03-3111251710ns5:RetainedEarningsAccumulatedLosses2024-03-3111251710ns5:RetainedEarningsAccumulatedLosses2023-03-3111251710ns5:PlantMachinery2023-04-012024-03-3111251710ns5:ComputerEquipment2023-04-012024-03-3111251710ns5:PlantMachinery2023-03-3111251710ns5:ComputerEquipment2023-03-3111251710ns5:PlantMachinery2024-03-3111251710ns5:ComputerEquipment2024-03-3111251710ns5:PlantMachinery2023-03-3111251710ns5:ComputerEquipment2023-03-3111251710ns10:OrdinaryShareClass12024-03-3111251710ns10:OrdinaryShareClass22024-03-3111251710ns10:OrdinaryShareClass32024-03-3111251710ns10:OrdinaryShareClass42024-03-31
REGISTERED NUMBER: 11251710 (England and Wales)












FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

SOLENT ANAESTHESIA AND PAIN RELIEF
SERVICE LTD
TRADING AS
SAPS-MEDICAL

SOLENT ANAESTHESIA AND PAIN RELIEF
SERVICE LTD (REGISTERED NUMBER: 11251710)
TRADING AS SAPS-MEDICAL

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


SOLENT ANAESTHESIA AND PAIN RELIEF
SERVICE LTD
TRADING AS SAPS-MEDICAL

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Dr M Luckmann
Mrs S Luckmann
Miss N Luckmann





SECRETARY: Mr J Luckmann





REGISTERED OFFICE: 1 Langley Court
Pyle Street
Newport
Isle of Wight
PO30 1LA





REGISTERED NUMBER: 11251710 (England and Wales)





ACCOUNTANTS: Mackenzies
Chartered Accountants
1 Langley Court
Pyle Street
Newport
Isle of Wight
PO30 1LA

SOLENT ANAESTHESIA AND PAIN RELIEF
SERVICE LTD (REGISTERED NUMBER: 11251710)
TRADING AS SAPS-MEDICAL

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible assets 4 6,627 5,322

CURRENT ASSETS
Cash at bank 35,075 45,087

CREDITORS
Amounts falling due within one year 5 13,718 13,740
NET CURRENT ASSETS 21,357 31,347
TOTAL ASSETS LESS CURRENT
LIABILITIES

27,984

36,669

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings 27,884 36,569
SHAREHOLDERS' FUNDS 27,984 36,669

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 November 2024 and were signed on its behalf by:



Dr M Luckmann - Director


SOLENT ANAESTHESIA AND PAIN RELIEF
SERVICE LTD (REGISTERED NUMBER: 11251710)
TRADING AS SAPS-MEDICAL

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

Solent Anaesthesia and Pain Relief Service Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance
Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

SOLENT ANAESTHESIA AND PAIN RELIEF
SERVICE LTD (REGISTERED NUMBER: 11251710)
TRADING AS SAPS-MEDICAL

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£ £ £
COST
At 1 April 2023 1,353 9,916 11,269
Additions 307 2,851 3,158
Disposals - (474 ) (474 )
At 31 March 2024 1,660 12,293 13,953
DEPRECIATION
At 1 April 2023 178 5,769 5,947
Charge for year 339 1,364 1,703
Eliminated on disposal - (324 ) (324 )
At 31 March 2024 517 6,809 7,326
NET BOOK VALUE
At 31 March 2024 1,143 5,484 6,627
At 31 March 2023 1,175 4,147 5,322

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Corporation tax 12,484 12,469
Social security and other taxes 40 26
Directors' current accounts 897 978
Accrued expenses 297 267
13,718 13,740

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £ £
50 Ordinary A £1 50 50
30 Ordinary B £1 30 30
10 Ordinary C £1 10 10
10 Ordinary D £1 10 10
100 100